134 related articles for article (PubMed ID: 18646190)
1. Chemoprevention of glandular stomach carcinogenesis through duodenogastric reflux in rats by a COX-2 inhibitor.
Oba M; Miwa K; Fujimura T; Harada S; Sasaki S; Hattori T
Int J Cancer; 2008 Oct; 123(7):1491-8. PubMed ID: 18646190
[TBL] [Abstract][Full Text] [Related]
2. A selective cyclooxygenase-2 inhibitor prevents inflammation-related squamous cell carcinogenesis of the forestomach via duodenogastric reflux in rats.
Oba M; Miwa K; Fujimura T; Harada S; Sasaki S; Oyama K; Ohta T; Hattori T
Cancer; 2009 Jan; 115(2):454-64. PubMed ID: 19110997
[TBL] [Abstract][Full Text] [Related]
3. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
[TBL] [Abstract][Full Text] [Related]
4. Late administration of a specific COX-2 inhibitor does not treat and/or prevent progression of gastric tumors in rats submitted to duodenogastric reflux procedure.
Rodrigues PA; Naresse LE; Rodrigues MA; Kobayasi S
Acta Cir Bras; 2013 Jun; 28(6):453-7. PubMed ID: 23743684
[TBL] [Abstract][Full Text] [Related]
5. A COX-2 inhibitor prevents the esophageal inflammation-metaplasia-adenocarcinoma sequence in rats.
Oyama K; Fujimura T; Ninomiya I; Miyashita T; Kinami S; Fushida S; Ohta T; Koichi M
Carcinogenesis; 2005 Mar; 26(3):565-70. PubMed ID: 15564290
[TBL] [Abstract][Full Text] [Related]
6. [A COX-2 inhibitor suppresses esophageal inflammation-metaplasia-adenocarcinoma sequence in rats].
Miwa K; Oyama K; Fujimura T
Nihon Rinsho; 2005 Aug; 63(8):1387-93. PubMed ID: 16101227
[TBL] [Abstract][Full Text] [Related]
7. [Cyclooxygenase (COX)-2 expression in a rat duodenoesophageal reflux model and chemoprevention of adenocarcinoma by the selective COX-2 inhibitor nimesulide].
Oyama K; Fujimura T; Ninomiya I; Miyashita T; Kinami S; Fushida S; Ohta T
Nihon Shokakibyo Gakkai Zasshi; 2007 Aug; 104(8):1183-91. PubMed ID: 17675820
[TBL] [Abstract][Full Text] [Related]
8. Expression of cyclooxygenase 2, microsomal prostaglandin E synthase 1, and EP receptors is increased in rat oesophageal squamous cell dysplasia and Barrett's metaplasia induced by duodenal contents reflux.
Jang TJ; Min SK; Bae JD; Jung KH; Lee JI; Kim JR; Ahn WS
Gut; 2004 Jan; 53(1):27-33. PubMed ID: 14684572
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers.
Xin B; Yokoyama Y; Shigeto T; Futagami M; Mizunuma H
Cancer; 2007 Aug; 110(4):791-800. PubMed ID: 17582802
[TBL] [Abstract][Full Text] [Related]
10. [Prophylactic effect of a selective COX-2 inhibitor celecoxib on carcinogen-induced gastric premalignant lesions in rats].
Tang BD; Zeng ZR; Hu PJ
Ai Zheng; 2006 Oct; 25(10):1205-9. PubMed ID: 17059761
[TBL] [Abstract][Full Text] [Related]
11. [The renal protective effect of selective cyclooxygenase-2 inhibitor on obstructive nephropathy].
Zuo Y; Ma J; Gu Y; Yang H; Lin S
Zhonghua Nei Ke Za Zhi; 2002 Dec; 41(12):825-8. PubMed ID: 12654237
[TBL] [Abstract][Full Text] [Related]
12. Specific COX-2 inhibitor, meloxicam, suppresses proliferation and induces apoptosis in human HepG2 hepatocellular carcinoma cells.
Li J; Chen X; Dong X; Xu Z; Jiang H; Sun X
J Gastroenterol Hepatol; 2006 Dec; 21(12):1814-20. PubMed ID: 17074019
[TBL] [Abstract][Full Text] [Related]
13. Selective cyclooxygenase-2 inhibition prevents alveolar bone loss in experimental periodontitis in rats.
Bezerra MM; de Lima V; Alencar VB; Vieira IB; Brito GA; Ribeiro RA; Rocha FA
J Periodontol; 2000 Jun; 71(6):1009-14. PubMed ID: 10914805
[TBL] [Abstract][Full Text] [Related]
14. [Duodenogastric reflux and gastric carcinogenesis in rats].
Hasegawa H
Nihon Shokakibyo Gakkai Zasshi; 1991 Aug; 88(8):1517-24. PubMed ID: 1942605
[TBL] [Abstract][Full Text] [Related]
15. Meloxicam inhibits the growth of non-small cell lung cancer.
Tsubouchi Y; Mukai S; Kawahito Y; Yamada R; Kohno M; Inoue K; Sano H
Anticancer Res; 2000; 20(5A):2867-72. PubMed ID: 11062695
[TBL] [Abstract][Full Text] [Related]
16. Role of pancreatic trypsin in chronic esophagitis induced by gastroduodenal reflux in rats.
Naito Y; Uchiyama K; Kuroda M; Takagi T; Kokura S; Yoshida N; Ichikawa H; Yoshikawa T
J Gastroenterol; 2006 Mar; 41(3):198-208. PubMed ID: 16699853
[TBL] [Abstract][Full Text] [Related]
17. [Effect of selective cyclooxygenase -2 inhibitor on the renal lesion of streptozotocin-induced diabetic rats and its possible mechanism].
Zuo Y; Gu Y; Ma J; Lin S
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(4):239-43. PubMed ID: 11953170
[TBL] [Abstract][Full Text] [Related]
18. [Mutagenicity of gastric and duodenal juice on gastric carcinogenesis in rats with duodenal reflux].
Matsumoto H
Nihon Geka Gakkai Zasshi; 1994 Jun; 95(6):368-75. PubMed ID: 8052222
[TBL] [Abstract][Full Text] [Related]
19. Duodenogastric reflux increases the penetration of N-3H-methyl-N-nitro-N-nitrosoguanidine into the antral mucosa of rats: a possible role for mucosal erosions and increased cell proliferation in gastric carcinogenesis.
Øvrebø KK; Svanes K; Aase S; Grong K; Sørbye H
Jpn J Cancer Res; 2002 May; 93(5):484-94. PubMed ID: 12036443
[TBL] [Abstract][Full Text] [Related]
20. Possible role of duodenogastric reflux on the development of remnant gastric carcinoma induced by N-methyl-N'-nitro-N-nitrosoguanidine in rats.
Nishidoi H; Koga S; Kaibara N
J Natl Cancer Inst; 1984 Jun; 72(6):1431-5. PubMed ID: 6587160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
